PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 1, 2026Open Access

Biopharmaceuticals in Contemporary India: Evolution, Market Dynamics, Policy Landscape, and Future Prospects

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDevanssh Mehta*

Discussion

Loading...

Member takes

Overview

Review article examines biopharmaceutical growth in India, highlighting market trends and regulatory challenges.

Key Points

  • This review aims to evaluate the evolution and current landscape of the biopharmaceutical sector in India.
  • Systematic examination of the biopharmaceutical industry’s structural and market evolution.
  • Analysis of regulatory frameworks, technological advancements, and translational challenges.
  • Evaluation of key segments including biosimilars, vaccines, and monoclonal antibodies.
  • India's biopharmaceutical market projected to grow at 8.3% CAGR through 2033.
  • Bioeconomy expected to reach USD 195.3 billion by 2025, contributing nearly 5% to GDP.
  • Emergence of over 11,000 biotech startups and government initiatives enhancing global competitiveness.

Cite This Study

Devanssh Mehta* (2026) studied this question.

synapsesocial.com/papers/69f444d3967e944ac55679cchttps://doi.org/10.5281/zenodo.19875709
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1BIOPHARMACEUTICALS IN CONTEMPORARY INDIA: EVOLUTION, MARKET DYNAMICS, POLICY LANDSCAPE, AND FUTURE PROSPECTS2026
  2. 2The Future of Biopharmaceutical Industry: Innovations, Challenges, and Implications for Global Health Systems2026
  3. 3Review on India’s Pharmaceutical Resilience: Innovations and Challenges in Global Health and the COVID-19 Era2026
  4. 4Bio-entrepreneurs’ bugbear: Regulatory rigmarole2024 · 2 citations
  5. 5Pharmaceutical Industry and Access to Medicines: In-Depth Analysis2025